Anbogen, a Taiwan-based clinical-stage biotech startup, has announced a drug supply collaboration to evaluate the combin...
BeiGene, a China-based oncology company, has announced the opening of its flagship US facility in Hopewell, New Jersey, ...
Glenmark Specialty S.A., a subsidiary of Indian firm Glenmark Pharmaceuticals has announced an exclusive marketing and d...
BeiGene, a global, science-driven biotechnology company, has announced that its anti-cancer drug zanubrutinib, a Bruton&...
US-based startup Immune-Onc Therapeutics, Inc. has entered into a clinical trial collaboration and supply agreement with...
China's BeiGene has announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European o...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. have reached an agreement with BeiGene (Beijing) for licensing of Biocyto...
China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...
BeiGene has announced the official launch of the BeiGene Bioisland Innovation Centre (BIC) in Guangzhou, China to enable...
BeiGene, headquartered in China, has purchased a 42-acre site at the Princeton West Innovation Campus in Hopewell, N.J.,...
